Julius merges with Peachtree Bioresearch to boost reach and CNS know-how

Julius Clinical has merged with Peachtree BioResearch Solutions, citing expanded international reach and central nervous system (CNS) expertise as motivations.

The deal sees US-based Peachtree become a “Julius Clinical Company,” according to its website and builds “on nearly a decade of successful collaboration.” Financial terms of the deal were disclosed.

In a press statement, Julius Clinical CEO Martijn Wallert said, "This marks a significant step forward in expanding our presence and deepening our capabilities across North America and Europe.

“This natural evolution of our long-term successful relationship allows us to leverage our aligned strengths to become a more versatile and capable partner for our clients,” he added.

The Zeist, Netherlands-based trials contractor also said the merger would create an organization with expertise in various therapeutic areas, including CNS, cardio-metabolic, renal, and rare diseases.

According to its website, Peachtree staff has participated in over 175 interventional clinical studies in complex CNS disorders.

Julius declined to comment when contacted by Clinical Insider.

Expansion

The merger with Georgia-headquartered Peachtree comes a few months after Julius expanded its reach in Europe with an office in Krakow, southern Poland.

International expansion and expanded capabilities in CNS studies have been on the agenda since Boston, Massachusetts-based private equity investor Ampersand Capital Partners acquired Julius in 2023.

At the time, the firm said the investment would help with its “strategic vision of growing its geographic footprint while enhancing its therapeutic expertise in CNS, renal, cardio-metabolic, and infectious diseases.”

More recently, in 2024 Julius partnered with Australian CRO Avance Clinical in a deal designed to expand its international reach. Under the agreement, Julius Clinical clients are allowed to leverage Avance’s operations in Asia, Australia, and New Zealand.

DepositPhotos/mindscanner